RxDoctor Payments Data

Brian Fuller, MD

Adult Reconstructive Orthopaedic Surgery · Carrollton, TXNPI 1396972386

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $174,826 of the $218,477 with a category attached, or 80.0%. Encore Medical, LP accounts for 79.9% of it on its own, with 30 other manufacturers making up the rest. 2025 is the largest year on record at $122,073, more than ten times the $9,657 reported in 2019.

$218,477in general payments, 2019–2025

Across 269 payments — averaging $812.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Encore Medical, LP$175K
  • Kyocera Medical Technologies, Inc.$20K
  • Smith+Nephew$5K
  • Zimmer Biomet$5K
  • Histosonics, Inc.$2K
  • Brixton Biosciences, Inc.$2K
  • plus $9K from 25 others

What the payments were for

  • Consulting fees$174,82680%
  • Speaking & faculty fees$4,0502%
  • Travel & lodging$27,80513%
  • Food & beverage$8,0464%
  • Education$3,7502%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$218,477 in reported general payments places this provider in the 85th percentile of 86 adult reconstructive orthopaedic surgery providers in Texas.

See all adult reconstructive orthopaedic surgery providers in Texas

Medicare billing

Part B allowed, 2024
$406,091
Medicare patients
590
Services billed
4,599

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Tranexamic Acid183$7,324
Celecoxib231$6,860
Diclofenac Sodium485$5,451
Gabapentin273$1,918
Ondansetron OdtOndansetron179$1,896
Meloxicam425$1,174
Dexamethasone185$1,043
Cefadroxil181$1,020
Tramadol Hcl233$869
Oxycodone Hcl192$779
Methylprednisolone61$448
Tizanidine Hcl20$135
Ibuprofen12$94
Naproxen14$72
Amoxicillin65$69

Paid to pharmacies, not to this prescriber.

Other adult reconstructive orthopaedic surgery in Carrollton

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →